Results
|
|
13061.
|
Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia. [electronic resource] by
- Cortes, Jorge E
- Gambacorti-Passerini, Carlo
- Deininger, Michael W
- Mauro, Michael J
- Chuah, Charles
- Kim, Dong-Wook
- Milojkovic, Dragana
- le Coutre, Philipp
- Garcia-Gutierrez, Valentin
- Crescenzo, Rocco
- Mamolo, Carla
- Reisman, Arlene
- Hochhaus, Andreas
- Brümmendorf, Tim H
Producer: 20190612
In:
Journal of cancer research and clinical oncology vol. 145
Availability: No items available.
|
|
|
13062.
|
|
|
|
13063.
|
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study. [electronic resource] by
- Gambacorti-Passerini, Carlo
- Cortes, Jorge E
- Lipton, Jeff H
- Kantarjian, Hagop M
- Kim, Dong-Wook
- Schafhausen, Philippe
- Crescenzo, Rocco
- Bardy-Bouxin, Nathalie
- Shapiro, Mark
- Noonan, Kay
- Leip, Eric
- DeAnnuntis, Liza
- Brümmendorf, Tim H
- Khoury, H Jean
Producer: 20191002
In:
Haematologica vol. 103
Availability: No items available.
|
|
|
13064.
|
|
|
|
13065.
|
|
|
|
13066.
|
|
|
|
13067.
|
|
|
|
13068.
|
|
|
|
13069.
|
|
|
|
13070.
|
|
|
|
13071.
|
|
|
|
13072.
|
|
|
|
13073.
|
|
|
|
13074.
|
|
|
|
13075.
|
|
|
|
13076.
|
|
|
|
13077.
|
|
|
|
13078.
|
|
|
|
13079.
|
|
|
|
13080.
|
|